INTRATHECAL CLONIDINE FOR REFRACTORY DETRUSOR HYPERREFLEXIA IN SPINAL-CORD INJURED PATIENTS - A PRELIMINARY-REPORT

Citation
P. Denys et al., INTRATHECAL CLONIDINE FOR REFRACTORY DETRUSOR HYPERREFLEXIA IN SPINAL-CORD INJURED PATIENTS - A PRELIMINARY-REPORT, The Journal of urology, 160(6), 1998, pp. 2137-2138
Citations number
4
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
00225347
Volume
160
Issue
6
Year of publication
1998
Part
1
Pages
2137 - 2138
Database
ISI
SICI code
0022-5347(1998)160:6<2137:ICFRDH>2.0.ZU;2-O
Abstract
Purpose: We assessed the urodynamic effect of various doses of intrath ecal clonidine on refractory detrusor hyperreflexia in spinal cord inj ured patients. Materials and Methods: Doses of 15, 30 or 45 mu g. intr athecal clonidine or placebo were given to 5 chronic complete spinal c ord injured patients with detrusor hyperreflexia. Two cystometries wer e performed before and 5, 30, 60, 90, 120 and 180 minutes after each i njection. Results: A statistically significant dose dependent decrease in detrusor hyperreflexia was observed in each patient without signif icant side effect. Conclusions: Intrathecal clonidine may represent a conservative reversible treatment for detrusor hyperreflexia via a sub cutaneous programmable pump, like that used for baclofen, for spastici ty. The long-term efficacy needs to be evaluated.